Last Updated: 02/08/2024

Next generation malaria vaccines targeting the parasite cell surface

Objectives

In this project unique tools will be used to define sporozoites in precise genetic, protein and immunological detail – using these insights to design and test tomorrow’s malaria vaccines.

Principal Investigators / Focal Persons

Jacob Baum

Rationale and Abstract

More than half a million children die each year from malaria infection. Infection starts with a mosquito bite when sporozoites, the single-celled malaria parasite form, are released into the skin. To advance the possibility of an effective, critically needed malaria vaccine.

Thematic Categories

Vaccines (Immune Correlates)

Date

Jan 2024 — Dec 2028

Total Project Funding

$1.96M

Project Site

Australia

SHARE
SHARE